Rice, S. A.
Mikes, M.
Bibus, D.
Berdyshev, E.
Reisz, J. A.
Gehrke, S.
Bronova, I.
D’Alessandro, A.
Drew, K. L.
Funding for this research was provided by:
National Institute of General Medical Sciences of the National Institutes of Health (2P20GM103395)
National Institute of General Medical Sciences of the National Institutes of Health (P20GM130443)
NIH Common Fund (TL4GM118992)
NSF (1258179)
Article History
Received: 11 July 2020
Accepted: 20 October 2020
First Online: 14 January 2021
Competing interests
: SR, MM, EB, IB, AD, SG, JR declare no conflict of interest. KLD has a financial interest in Be Cool Pharmaceutics and DB has a financial interest in Lipid Technologies, LLC.